Collexis Connects the NIH Clinical and Translational Science Award Programs with CTSA Expert Platform
March 3, 2009
CTSA Experts Platform launch will Enable 60,000+ Researchers at 38 Institutions to Collaborate
COLUMBIA, SC – March 3, 2009 – Collexis Holdings Inc. (OTCBB: CLXS), a leading developer of semantic search and knowledge discovery software, announced today the launch of the world’s first CTSA Experts Platform drawing on the research profiles of 38 institutions and their more than 60,000 life science researchers. The platform is available to Collexis clients who are also winners of the Clinical Translational Science Awards (CTSA’s) from the National Institutes of Health. Institutions that are subscribers to the service will be able to search, rank, and visualize expert profiles from all 38 CTSA institutions.
“Among the goals of the National Institutes of Health CTSA awards are to accelerate bench to bedside discoveries into patient care, as well as to develop the infrastructure to support ongoing collaborative efforts in biomedical research,” said Dr. Christian Herzog, Managing Director at Collexis. “The Collexis CTSA Expert Platform will allow participants to achieve these important goals by matching basic researchers and clinical scientists within organizations, and across multiple awarded institutions.”
The new offering gives CTSA users a unique competitive advantage. It allows a researcher to identify partners from their organization and across the CTSA Consortia on any biomedical research topic(s). The platform automatically recommends collaborators from other institutions based on multiple areas of common research interests. Finally, the system will track and identify collaboration patterns among CTSA consortia members, allowing Collexis to give clients and NIH more information about how researchers work together and signaling ways that NIH can improve the CTSA program.
The Collexis Expert Platform approach to profiling life science researchers has become the standard with research intensive institutions. Current clients include Johns Hopkins, the National Institutes of Health, University of Michigan, Oregon Health Sciences University, The Medical College of Georgia, The University of Miami, the University of South Carolina, and more than 25 more leading medical research institutions.
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with operations in Cincinnati, Ohio and Cologne, Germany. Collexis now offers the world’s first pre-populated scientific social network for life science researchers, www.biomedexperts.com. Collexis’ proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as “finding needles in many haystacks.” Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis’ current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.
Disclaimer: National Institutes of Health (NIH) and the CTSA consortium is not considered a supporter or partner of Collexis. Reference to NIH or CTSA consortium in the above shall not be construed as a Government endorsement nor does it obligate NIH to a position on or about the Collexis Software.
